E322: Lecithin (Phospholipid Emulsifier & Viscosity Reducer) vs. E951: Aspartame (Dipeptide Sweetener / 200x)
Comparing 2 standards across 15 specifications. 15 key differences identified.
Lecithin (E322) is a complex mixture of zwitterionic polar phospholipids (phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol) derived from soybeans, sunflower seeds, or egg yolks, functioning as an amphiphilic oil-in-water surfactant and chocolate viscosity reducer.
E951 (Aspartame) is a methyl ester of the aspartic acid/phenylalanine dipeptide yielding ~200x the sweetness of sucrose. INS 951, ADI is 40 mg/kg bw/day, the historic sweetener in Diet Coke and tabletop sweetener packets.
Specification Comparison Table
15 Parameters| Parameter / Spec | ||
|---|---|---|
|
Acceptable Daily Intake (ADI)
|
Not Specified (Quantum Satis / GRAS under FDA 21 CFR 184.1400) | 40 mg / kg body weight per day (US FDA: 50 mg/kg) |
|
INS / E-Number
|
INS 322i (Lecithin) / INS 322ii (Partially Hydrolyzed) | — |
|
Primary Phospholipid Composition
|
19–21% Phosphatidylcholine (PC), 8–20% PE, 10–15% PI | — |
|
Hydrophilic-Lipophilic Balance (HLB)
|
HLB 4.0–6.0 (Standard unbleached) / HLB 8.0–10.0 (Enzymatically modified lyso-lecithin) | — |
|
Acetone-Insoluble Matter
|
≥ 60.0% (standard benchmark of active phospholipid content) | — |
|
Major Sources
|
Soybean (Glycine max), Sunflower (Helianthus annuus - non-GMO / allergen-free), Rapeseed, Egg yolk | — |
|
E-Number Code
|
— | E951 |
|
INS / Codex Number
|
— | INS 951 |
|
Functional Class
|
— | High-Intensity Artificial Sweetener |
|
Relative Sweetness Index
|
— | 200x Sucrose |
|
Caloric Value
|
— | 4.0 kcal / g (Negligible at use levels / ~0.1 kcal per serving) kcal/g |
|
Primary Mechanism
|
— | Stimulates T1R2/T1R3 sweet taste receptors with clean, sugar-like taste profile |
|
Common Target Foods
|
— | Diet sodas, tabletop sweetener packets (Equal), sugar-free gelatin desserts, drink mixes |
|
Dietary Compliance
|
— | Vegetarian, Halal, Kosher, Contains Phenylalanine (Warning for PKU patients mandatory) |
|
Safety Approval
|
— | EFSA Authorized / FDA Approved (21 CFR 172.804) |